Stock To Watch: LeMaitre Vascular, Inc. (NASDAQ:LMAT)


The leading market experts have placed a mean price target of $18.79 on LeMaitre Vascular, Inc. (NASDAQ:LMAT) stock. This price level, which is estimated to be attained in one-year indicates the mean of stock opinions given by the companies included in the First Call survey. The renowned research firms have predicted earnings of $0.12 a share for the upcoming quarter and $0.48 for the current fiscal. Technical View The technical analysis of LeMaitre Vascular, Inc. plainly substantiates that the 50-day moving average of LeMaitre Vascular, Inc. is $15.24, and stock is hovering -0.88 or -5.77% distant from $15.24. It is noted that the 200-day MA is $15.09, and LeMaitre Vascular, Inc. stock is $-0.73 or -4.83% off from this point. LeMaitre Vascular, Inc. (NASDAQ:LMAT) 52-week high is $18.44 and the 52-week low is $10.61. This explains if the stock moves $-4.08, it will post a 52-week high. In event of $+35.34% points decline, a 52-week low will be hit. Taking the Valuation Aspect To emphasize the valuation of LeMaitre Vascular, Inc., shareholders can apply financial tool known as price-to-earnings ratio. This financial ratio assesses stock’s valuation by considering the relative expense of the stock. Following this ratio, LeMaitre Vascular, Inc. (NASDAQ:LMAT) ratio came in at 31.98. The stock last ended the trading session at $14.36 and registered a market cap of $263.92M. To appraise firm’s growth, the shareholders take help of the Price-to-Earnings-Growth ratio. When a stock has a higher PEG ratio, it is suggestive of lower stock appreciation in approaching sessions. A stock comes in the group of undervalued stocks when its PEG ratio falls in between 0 and 1. LeMaitre Vascular, Inc. (NASDAQ:LMAT) PEG ratio is at 1.65.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 2 times, 1 visits today)